Matthew A Hulverson Selected Research

Matthew A Hulverson Research Topics

Disease

15	Cryptosporidiosis 10/2023 - 12/2016
12	Infections 12/2021 - 12/2016
5	Toxoplasmosis 10/2023 - 01/2016
4	Diarrhea 12/2020 - 01/2017
4	Malaria 06/2020 - 01/2014
3	Cardiotoxicity 10/2017 - 01/2016
3	African Trypanosomiasis (Nagana) 01/2017 - 02/2014
2	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 08/2023
2	Giardiasis 01/2023 - 01/2022
2	Body Weight (Weight, Body) 12/2020 - 01/2019
2	Parasitic Diseases (Parasitic Disease) 01/2020 - 09/2017
2	Parasitemia 07/2014 - 09/2012
2	Chagas Disease (American Trypanosomiasis) 07/2014 - 09/2012
1	Bacillary Dysentery (Shigellosis) 01/2019
1	Fever (Fevers) 01/2018
1	Eye Infections 01/2017
1	Congenital Toxoplasmosis 01/2017
1	Persistent Infection 12/2016
1	Encephalomyelitis (Myeloencephalitis) 12/2016
1	Neglected Diseases 07/2014

Drug/Important Bio-Agent (IBA)

17	Phosphotransferases (Kinase)IBA 01/2023 - 12/2016
10	calcium-dependent protein kinaseIBA 10/2023 - 01/2016
3	BKI 1369IBA 12/2020 - 01/2018
3	Antiparasitic Agents (Antiparasitics)IBA 01/2017 - 02/2014
2	HexokinaseIBA 03/2024 - 08/2023
2	enzalutamideIBA 03/2024 - 08/2023
2	AntigensIBA 12/2021 - 01/2019
2	pyrrolopyrimidineIBA 01/2021 - 01/2019
2	AminesIBA 01/2018 - 01/2017
2	BKI-1553IBA 01/2018 - 12/2016
2	Protein Kinases (Protein Kinase)IBA 09/2017 - 12/2016
2	Ether (Diethyl Ether)IBA 01/2017 - 01/2016
2	CalciumIBA 12/2016 - 12/2016
2	posaconazole FDA Link 07/2014 - 09/2012
2	EnzymesIBA 01/2014 - 09/2012
1	VaccinesIBA 10/2023
1	Albendazole (Albenza)FDA Link 01/2023
1	Metronidazole (Metric)FDA LinkGeneric 01/2023
1	NitroimidazolesIBA 01/2023
1	QuinolonesIBA 12/2021
1	pyrimidineIBA 01/2021
1	imidazoleIBA 01/2021
1	Contraceptive Agents (Contraceptives)IBA 06/2020
1	Complement System Proteins (Complement)IBA 06/2020
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2019
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019
1	toltrazurilIBA 01/2019
1	nitazoxanide (NTZ)FDA Link 01/2019
1	Ampicillin (Omnipen)FDA LinkGeneric 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	AntibodiesIBA 01/2019
1	Methionine-tRNA LigaseIBA 01/2019
1	imidazopyridineIBA 01/2019
1	Interferon-gamma (Interferon, gamma)IBA 01/2019
1	Lysine-tRNA LigaseIBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2018
1	NaphthoquinonesIBA 01/2017
1	buparvaquoneIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	prolyl T RNA synthetaseIBA 01/2017
1	Potassium Channels (Potassium Channel)IBA 01/2017
1	BenzamidesIBA 01/2017
1	Urea (Carbamide)FDA LinkGeneric 01/2017
1	Clemastine (Clemastine Fumarate)FDA LinkGeneric 07/2014
1	Amlodipine (Norvasc)FDA LinkGeneric 07/2014
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 07/2014
1	Antimalarials (Antimalarial Agents)IBA 01/2014
1	artemisinin (artemisinine)IBA 01/2014
1	SterolsIBA 09/2012
1	AzolesIBA 09/2012
1	benzonidazole (benznidazole)IBA 09/2012
1	tipifarnib (R115777)IBA 09/2012

Therapy/Procedure

14	Therapeutics 01/2022 - 01/2014
2	Castration 03/2024 - 08/2023
1	Oral Administration 01/2019
1	Drug Therapy (Chemotherapy) 01/2017
1	Aftercare (After-Treatment) 12/2016